JOSLYN TAPEC: Open Payments
NPI 1639727977 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,309 in 74 payments from 20 companies in 2025. Trend: 2023 $656 · 2024 $981 · 2025 $1,309
Food & beverage: $1,309
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $208 |
| Corcept Therapeutics | 8 | $183 |
| Phathom Pharmaceuticals, Inc. | 6 | $147 |
| PFIZER INC. | 10 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Novo Nordisk Inc | 3 | $82 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $76 |
| Lilly USA, LLC | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| GlaxoSmithKline, LLC. | 2 | $45 |
Products named: Korlym, VOQUEZNA, QULIPTA, PREVNAR 20, CAPLYTA, Rybelsus, XIFAXAN, UBRELVY.
Industry payments across WA — which companies pay providers there.
